Police officials in China have arrested two more sales executives of AstraZeneca PLC as part of its pharmaceutical industry investigations in the country.

The pharmaceutical giant, AstraZeneca has said that it is not involved in any wrongdoing in crackdown on bribery in the pharmaceutical industry in China. The police had first arrived at Astra's Shanghai headquarters on Friday. The police has taken three employees of the company for questioning. The company said that the three employees in the investigations were all Chinese nationals.

China's National Health and Family Planning Commission s announced that 39 hospital employees in China's southern Guangdong province will face punishment for accepting 2.82 million yuan from two pharmaceutical companies from January 2010 to December 2012. The authority did not name the companies involved in the investigations.

Meanwhile, three senior level management officials of GlaxoSmithKline are now in China to prepare a response to the allegations of bribery and corruption in the country. Abbas Hussain, GSK President Emerging Markets as well as the group's global head of internal audit and a senior legal official are in China for controlling the crisis. Police in China had accused GSK of bribing officials and doctors on Monday for increasing sales and the prices of medicines in the Chinese markets.